Abstract
Bromofenofos (BF) and dephosphate bromofenofos (DBF) were administered at equimolar doses to rats on day 10 of pregnancy. The dams were killed on day 21, and the fetuses were removed, weighed and examined by routine teratological methods. BF caused a significant increase in fetal resorptions at 58.2 mg/kg. Approximately 69% of the implants were resorbed at this dose level. In rats given DBF equimolar to 58.2 mg/kg BF, the resorption rate was 81.9%. Administration of BF resulted in a dose-dependent decrease in fetal body weights which was significant at 29.1 mg/kg or more. DBF caused a significant decrease in fetal body weights, beginning at 25.1 mg/ kg equimolar to 29.1 mg/kg BF, and the decreased fetal body weights were almost the same between BF and DBF. BF at 58.2 mg/kg induced significant gross and skeletal malformations, with incidences of 35.6 and 27.6%, respectively. In rats given DBF equimolar to 58.2 mg/kg BF, gross and skeletal malformations were seen in 54.5 and 61.5% of the fetuses, respectively. There were similarities in the types of malformations observed between BF and DBF. Both compounds induced no significant internal malformations. It was concluded from these results that the embryolethal and teratogenic effects of BF is due to its metabolite, DBF, which cannot respond to cholinesterase inhibition.
References
Boer HB de, Kleinepier JF (1969) Method for the determination of the anti-liverfluke compound Ph. 1882 in milk after the treatment of cattle against distomatosis. Neth Milk Dairy J 23: 163–167
Budreau CH, Singh RP (1973) Teratogenicity and embryotoxicity of demeton and fenthion in CF # I mouse embryos. Toxicol Appl Pharmacol 24: 324–332
Fukuhara K, Matsuki Y, Nambara T (1985) Determination of dephosphate-bromophenophos excreted in cow's milk by gas-liquid chromatography using an electron capture detector. J Food Hyg Soc Japan 26: 658–661 (in Japanese)
Heeschen H, Blüthgen A, Tolle A (1973) Zum Nachweis, Vorkommen und zur Lebensmittel-hygienischen Bedeutung von Fascioliziden in der Milch. In: Referat Fascolose Symposium. October 3–4, Teckenburg, pp 18–36
Meer S van der, Pouwels H (1969) 4,4', 6,6'-Tetrabromo-2,2'-biphenyldiol mono (dihydrogen phosphate). A new agent for combating distomatosis. J Med Chem 12: 534–535
Poul JM, Dagorn M (1982) Etude de la toxicité du bromophénophos administré par voie orale pendant trois mois chez le rat. Rec Méd Vét 158: 363–368
Yoshimura H (1987) Embryolethal and teratogenic effects of bromofenofos in rats. Arch Toxicol 60: 319–324
Yoshimura H, Delatour P (1986) Embryolethality of bromofenofos in rats. Toxicol Lett 31: 243–247
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yoshimura, H. Comparative embryolethal effect of bromofenofos and dephosphate bromofenofos in rats. Arch Toxicol 60, 325–327 (1987). https://doi.org/10.1007/BF01234673
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01234673